Monday, June 4, 2018

Colorado Board of Pharmacy Stakeholder Meeting Scheduled for June 11, 2018 Regarding possible amendments to board rules

Stakeholder Meeting - June 11

The Colorado State Board of Pharmacy is considering amending Board Rules 3.05.00, 6.00.00, 14.00.40, 14.00.80, 17.00.00 and 25.00.14 to improve the administration and enforcement of the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act.
Colorado law permits agencies to informally solicit views from interested stakeholders concerning proposed draft rules before commencing the formal rulemaking process. We invite you to share your thoughts and recommendations as we improve a preliminary draft of proposed rules to regulate the practice of pharmacy in Colorado. 
Draft Rules and Meeting Materials
  • Download the official stakeholder notice.
  • Download the draft rules for the meeting:
    • Rule 3.05.00 - The purpose of the proposed addition of Board Rule 3.05.00 is to specify the requirements for pharmacists when prescribing over-the-counter medications. 
    • Rule 6.00.00 - The purpose of any proposed amendments to Board Rule 6.00.00 is to address the requirements of drug therapy management. 
    • Rule 14.00.40 and 14.00.80 - The purpose of the proposed amendments to Board Rules 14.00.40 and 14.00.80 is to allow, and to address the corresponding consultant pharmacist expectations as to visitation frequency, a telepharmacy to dispense up to 50,000 dispensing units in a calendar year. 
    • Rule 17.00.00 - The purpose of the proposed amendments to Board Rule 17.00.00 is to address the education requirements to participate in statewide protocols as part of collaborative pharmacy. 
    • Rule 17.00.00 Appendix A
    • Rule 17.00.00 Appendix B
    • Rule 25.00.14 - The purpose of the proposed amendment to Board Rule 25.00.14 is to allow, and to address the corresponding expectations of involved pharmacists, the packaging and labeling of medication for a specific patient by an automated device at a specialized prescription drug outlet. 
Meeting Information
  • Monday, June 11, 2018 at 8:30 a.m. (MDT)
Three Ways to Participate
  1. In Person: Civic Center Plaza, 1560 Broadway, Conference Room 110D, Denver, CO 80202
  2. By Webinar: Register at https://attendee.gotowebinar.com/register/4125068951236793858.
  3. By Written Comment: Provide written comments in advance or after the meeting to dora_pharmacyboard@state.co.us no later than June 8, 2018, at 5 p.m. (MDT)
Meeting Format
Attendees may provide comments, concerns, and proposals to the program in writing or in person at the meeting. Participants will be able to discuss topics brought forward during the meeting. Program staff will moderate the discussion to ensure there is an equitable opportunity for all stakeholders to actively participate, and to ensure comments and suggested changes are collected for Board consideration and future rulemaking. This meeting is not a formal rulemaking hearing.
quoted from here

No comments: